HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yong Yi Selected Research

naratuximab emtansine

9/2017The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
11/2013A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yong Yi Research Topics

Disease

43Neoplasms (Cancer)
03/2022 - 11/2010
20Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2012
9Neoplasm Metastasis (Metastasis)
11/2021 - 11/2010
5Cholangiocarcinoma
01/2021 - 01/2017
5Infections
01/2018 - 09/2009
4Inflammation (Inflammations)
01/2022 - 09/2015
3Carcinogenesis
01/2022 - 12/2018
3Liver Neoplasms (Liver Cancer)
03/2021 - 02/2016
2Fibrosis (Cirrhosis)
01/2022 - 06/2018
2Hepatitis
12/2021 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 01/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 03/2017
2Type 2 Diabetes Mellitus (MODY)
03/2019 - 01/2019
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2017 - 11/2013
1Colonic Neoplasms (Colon Cancer)
02/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Urinary Bladder Neoplasms (Bladder Cancer)
10/2021
1Hypoxia (Hypoxemia)
10/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2021
1Hemorrhage
03/2021
1Glioma (Gliomas)
01/2021
1Adenocarcinoma
01/2021
1Lung Neoplasms (Lung Cancer)
06/2020
1Liver Diseases (Liver Disease)
01/2020

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2021 - 03/2002
6Messenger RNA (mRNA)IBA
11/2021 - 11/2010
6Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2010
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2021 - 03/2017
4Indicators and Reagents (Reagents)IBA
01/2021 - 10/2016
4Metformin (Glucophage)FDA LinkGeneric
03/2019 - 01/2017
3EnzymesIBA
10/2021 - 06/2012
3Pharmaceutical PreparationsIBA
10/2021 - 03/2019
3Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2014
3CateninsIBA
01/2021 - 01/2020
3Cadherins (E-Cadherin)IBA
01/2020 - 01/2019
2Biological ProductsIBA
02/2022 - 04/2020
2sintilimabIBA
12/2021 - 12/2020
2CytokinesIBA
11/2021 - 07/2012
2MicroRNAs (MicroRNA)IBA
11/2021 - 01/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
10/2021 - 01/2019
2Capsules (Microcapsules)IBA
03/2021 - 01/2014
2LigandsIBA
12/2020 - 07/2012
2Glucose (Dextrose)FDA LinkGeneric
03/2019 - 03/2017
2TransferasesIBA
06/2018 - 01/2017
2AlbuminsIBA
01/2018 - 02/2017
2C-Reactive ProteinIBA
01/2018 - 03/2017
2naratuximab emtansineIBA
09/2017 - 11/2013
2Rituximab (Mabthera)FDA Link
09/2017 - 11/2013
2Immunoconjugates (Immunoconjugate)IBA
09/2017 - 11/2013
2AMP-Activated Protein KinasesIBA
03/2017 - 01/2017
2Vincristine (Oncovin)FDA LinkGeneric
01/2017 - 11/2013
2Conditioned Culture MediaIBA
04/2013 - 06/2012
2InterferonsIBA
01/2013 - 11/2012
1Ethylene Glycol (Monoethylene Glycol)IBA
03/2022
1Antiviral Agents (Antivirals)IBA
01/2022
1Insulin-Like Growth Factor Binding ProteinsIBA
01/2022
1Sorafenib (BAY 43-9006)FDA Link
12/2021
1Circular RNAIBA
11/2021
1ErbB Receptors (EGF Receptor)IBA
10/2021
1ProdrugsIBA
10/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2021
1Stimuli Responsive PolymersIBA
10/2021
1Vitamin KFDA Link
03/2021
1Alkaline PhosphataseIBA
03/2021
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2021
1Protein Isoforms (Isoforms)IBA
01/2021
1Long Noncoding RNAIBA
01/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1CyclinsIBA
01/2021
1Oncogene Proteins (Oncogene Protein)IBA
01/2021
1OsteopontinIBA
01/2021
1Immunoglobulin G (IgG)IBA
12/2020
1Monoclonal AntibodiesIBA
12/2020
1Programmed Cell Death 1 ReceptorIBA
12/2020
1Deubiquitinating EnzymesIBA
06/2020
1Twist-Related Protein 1IBA
06/2020
1Ribosomal Proteins (Ribosomal Protein)IBA
04/2020
1ribosomal protein S11IBA
04/2020
1AMP-Activated Protein Kinase KinasesIBA
01/2020
1ApolipoproteinsIBA
01/2020
1Neuraminidase (Sialidase)IBA
01/2020
1Chemokine CXCL5IBA
01/2020
1Cyclin D1IBA
01/2020
1low density lipoprotein inhibitorIBA
01/2020
1LipidsIBA
01/2020
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
01/2020
1IntegrinsIBA
01/2019
1p38 Mitogen-Activated Protein KinasesIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1Eosine Yellowish-(YS) (Eosin)IBA
12/2018

Therapy/Procedure

10Therapeutics
03/2022 - 01/2017
6Hepatectomy
01/2022 - 09/2015
4Immunotherapy
12/2020 - 05/2013
2Drug Therapy (Chemotherapy)
10/2021 - 01/2013
1Adjuvant Chemotherapy
02/2022
1Mastectomy (Mammectomy)
01/2022
1Segmental Mastectomy (Lumpectomy)
01/2022
1Photochemotherapy (Photodynamic Therapy)
10/2021